Bimekizumab Safety in Patients with Moderate to Severe Psoriasis: Analysis of Pooled Data from Phase 2 and 3 Clinical Trials. (2021). SKIN The Journal of Cutaneous Medicine, 5(1), s21. https://doi.org/10.25251/skin.5.supp.21